Avanos Medical Inc. (AVNS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Avanos Medical Inc.

    NYSE: AVNS · Real-Time Price · USD
    12.41
    0.39 (3.24%)
    At close: Sep 11, 2025, 3:59 PM
    12.19
    1.33%
    Pre-market: Sep 11, 2025, 09:03 AM EDT

    Avanos Medical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 687.8M 673.3M 684.1M 744.6M
    Cost of Revenue
    		 306.5M 293.6M 289.9M 364.7M
    Gross Profit
    		 381.3M 379.7M 394.2M 379.9M
    Operating Income
    		 40M 65M 41.9M 86.8M
    Interest Income
    		 5.1M 2.9M 1.2M 200K
    Pretax Income
    		 -403.3M -7.9M 26.7M 7.3M
    Net Income
    		 -392.1M -61.8M 50.5M 6.3M
    Selling & General & Admin
    		 315.1M 287.5M 323.1M 260.8M
    Research & Development
    		 26.2M 27.2M 30.6M 32.3M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 341.3M 314.7M 352.3M 293.1M
    Interest Expense
    		 12.2M 15M 10M 3.3M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 647.8M 608.3M 642.2M 657.8M
    Income Tax Expense
    		 -17M 2M 5.2M 1M
    Shares Outstanding (Basic)
    		 46M 46.6M 46.9M 48.1M
    Shares Outstanding (Diluted)
    		 46M 46.6M 47.3M 48.6M
    EPS (Basic)
    		 -8.53 -1.33 1.08 0.13
    EPS (Diluted)
    		 -8.53 -1.33 1.07 0.13
    EBITDA
    		 -345.6M 50.6M 77.8M 48.9M
    EBIT
    		 -391.1M 7.1M 36.7M 10.6M
    Depreciation & Amortization
    		 45.5M 43.5M 41.1M 38.3M

    Add to Watchlist